Click for best price
Tinea Corporis Drugs Market Size, Share 2023
Tinea corporis, also known as?ringworm, is a superficial?fungal infection?(dermatophytosis) of the arms and legs, especially on?glabrous skin; however, it may occur on any part of the body. It is similar to other forms of?tinea.
This report aims to provide a comprehensive presentation of the global market for Tinea Corporis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tinea Corporis Drugs. This report contains market size and forecasts of Tinea Corporis Drugs in global, including the following market information:
Global Tinea Corporis Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Tinea Corporis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antifungals Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tinea Corporis Drugs include Sun Pharmaceutical, Teva, Glenmark, Aurobindo, AvKare, Novartis, Sebela and Bayer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tinea Corporis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tinea Corporis Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Tinea Corporis Drugs Market Segment Percentages, by Type, 2022 (%)
Antifungals
Steroids
Anti-Infective Combinations
Global Tinea Corporis Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Tinea Corporis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Tinea Corporis Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Tinea Corporis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tinea Corporis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tinea Corporis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tinea Corporis Drugs, market overview.
Chapter 2: Global Tinea Corporis Drugs market size in revenue.
Chapter 3: Detailed analysis of Tinea Corporis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tinea Corporis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Tinea Corporis Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tinea Corporis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tinea Corporis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tinea Corporis Drugs Overall Market Size
2.1 Global Tinea Corporis Drugs Market Size: 2022 VS 2030
2.2 Global Tinea Corporis Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tinea Corporis Drugs Players in Global Market
3.2 Top Global Tinea Corporis Drugs Companies Ranked by Revenue
3.3 Global Tinea Corporis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Tinea Corporis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tinea Corporis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tinea Corporis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Tinea Corporis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Tinea Corporis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tinea Corporis Drugs Market Size Markets, 2022 & 2030
4.1.2 Antifungals
4.1.3 Steroids
4.1.4 Anti-Infective Combinations
4.2 By Type - Global Tinea Corporis Drugs Revenue & Forecasts
4.2.1 By Type - Global Tinea Corporis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Tinea Corporis Drugs Revenue, 2024-2030
4.2.3 By Type - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tinea Corporis Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Tinea Corporis Drugs Revenue & Forecasts
5.2.1 By Application - Global Tinea Corporis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Tinea Corporis Drugs Revenue, 2024-2030
5.2.3 By Application - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Tinea Corporis Drugs Market Size, 2022 & 2030
6.2 By Region - Global Tinea Corporis Drugs Revenue & Forecasts
6.2.1 By Region - Global Tinea Corporis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Tinea Corporis Drugs Revenue, 2024-2030
6.2.3 By Region - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Tinea Corporis Drugs Revenue, 2018-2030
6.3.2 US Tinea Corporis Drugs Market Size, 2018-2030
6.3.3 Canada Tinea Corporis Drugs Market Size, 2018-2030
6.3.4 Mexico Tinea Corporis Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Tinea Corporis Drugs Revenue, 2018-2030
6.4.2 Germany Tinea Corporis Drugs Market Size, 2018-2030
6.4.3 France Tinea Corporis Drugs Market Size, 2018-2030
6.4.4 U.K. Tinea Corporis Drugs Market Size, 2018-2030
6.4.5 Italy Tinea Corporis Drugs Market Size, 2018-2030
6.4.6 Russia Tinea Corporis Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Tinea Corporis Drugs Market Size, 2018-2030
6.4.8 Benelux Tinea Corporis Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Tinea Corporis Drugs Revenue, 2018-2030
6.5.2 China Tinea Corporis Drugs Market Size, 2018-2030
6.5.3 Japan Tinea Corporis Drugs Market Size, 2018-2030
6.5.4 South Korea Tinea Corporis Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Tinea Corporis Drugs Market Size, 2018-2030
6.5.6 India Tinea Corporis Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Tinea Corporis Drugs Revenue, 2018-2030
6.6.2 Brazil Tinea Corporis Drugs Market Size, 2018-2030
6.6.3 Argentina Tinea Corporis Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tinea Corporis Drugs Revenue, 2018-2030
6.7.2 Turkey Tinea Corporis Drugs Market Size, 2018-2030
6.7.3 Israel Tinea Corporis Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Tinea Corporis Drugs Market Size, 2018-2030
6.7.5 UAE Tinea Corporis Drugs Market Size, 2018-2030
7 Tinea Corporis Drugs Companies Profiles
7.1 Sun Pharmaceutical
7.1.1 Sun Pharmaceutical Company Summary
7.1.2 Sun Pharmaceutical Business Overview
7.1.3 Sun Pharmaceutical Tinea Corporis Drugs Major Product Offerings
7.1.4 Sun Pharmaceutical Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.1.5 Sun Pharmaceutical Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Tinea Corporis Drugs Major Product Offerings
7.2.4 Teva Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Glenmark
7.3.1 Glenmark Company Summary
7.3.2 Glenmark Business Overview
7.3.3 Glenmark Tinea Corporis Drugs Major Product Offerings
7.3.4 Glenmark Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.3.5 Glenmark Key News & Latest Developments
7.4 Aurobindo
7.4.1 Aurobindo Company Summary
7.4.2 Aurobindo Business Overview
7.4.3 Aurobindo Tinea Corporis Drugs Major Product Offerings
7.4.4 Aurobindo Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.4.5 Aurobindo Key News & Latest Developments
7.5 AvKare
7.5.1 AvKare Company Summary
7.5.2 AvKare Business Overview
7.5.3 AvKare Tinea Corporis Drugs Major Product Offerings
7.5.4 AvKare Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.5.5 AvKare Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Tinea Corporis Drugs Major Product Offerings
7.6.4 Novartis Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Sebela
7.7.1 Sebela Company Summary
7.7.2 Sebela Business Overview
7.7.3 Sebela Tinea Corporis Drugs Major Product Offerings
7.7.4 Sebela Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.7.5 Sebela Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Company Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Tinea Corporis Drugs Major Product Offerings
7.8.4 Bayer Tinea Corporis Drugs Revenue in Global Market (2018-2023)
7.8.5 Bayer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tinea Corporis Drugs Market Opportunities & Trends in Global Market
Table 2. Tinea Corporis Drugs Market Drivers in Global Market
Table 3. Tinea Corporis Drugs Market Restraints in Global Market
Table 4. Key Players of Tinea Corporis Drugs in Global Market
Table 5. Top Tinea Corporis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tinea Corporis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tinea Corporis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tinea Corporis Drugs Product Type
Table 9. List of Global Tier 1 Tinea Corporis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tinea Corporis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tinea Corporis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Tinea Corporis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tinea Corporis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Tinea Corporis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Tinea Corporis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tinea Corporis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Tinea Corporis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Tinea Corporis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tinea Corporis Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tinea Corporis Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tinea Corporis Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tinea Corporis Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tinea Corporis Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tinea Corporis Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Sun Pharmaceutical Company Summary
Table 31. Sun Pharmaceutical Tinea Corporis Drugs Product Offerings
Table 32. Sun Pharmaceutical Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sun Pharmaceutical Key News & Latest Developments
Table 34. Teva Company Summary
Table 35. Teva Tinea Corporis Drugs Product Offerings
Table 36. Teva Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Key News & Latest Developments
Table 38. Glenmark Company Summary
Table 39. Glenmark Tinea Corporis Drugs Product Offerings
Table 40. Glenmark Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Glenmark Key News & Latest Developments
Table 42. Aurobindo Company Summary
Table 43. Aurobindo Tinea Corporis Drugs Product Offerings
Table 44. Aurobindo Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Aurobindo Key News & Latest Developments
Table 46. AvKare Company Summary
Table 47. AvKare Tinea Corporis Drugs Product Offerings
Table 48. AvKare Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. AvKare Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Tinea Corporis Drugs Product Offerings
Table 52. Novartis Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Sebela Company Summary
Table 55. Sebela Tinea Corporis Drugs Product Offerings
Table 56. Sebela Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Sebela Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Tinea Corporis Drugs Product Offerings
Table 60. Bayer Tinea Corporis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer Key News & Latest Developments
List of Figures
Figure 1. Tinea Corporis Drugs Segment by Type in 2022
Figure 2. Tinea Corporis Drugs Segment by Application in 2022
Figure 3. Global Tinea Corporis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tinea Corporis Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Tinea Corporis Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tinea Corporis Drugs Revenue in 2022
Figure 8. By Type - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Tinea Corporis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Tinea Corporis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 16. US Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 28. China Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Tinea Corporis Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Tinea Corporis Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Sun Pharmaceutical Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Glenmark Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Aurobindo Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AvKare Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sebela Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer Tinea Corporis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
